All Stories

  1. Effects of Pioglitazone on Nonalcoholic Fatty Liver Disease in the Absence of Constitutive Androstane Receptor Expression
  2. Changes in Body Compositions and Basal Metabolic Rates during Treatment of Graves’ Disease
  3. Changes in the clinicopathological characteristics and genetic alterations of follicular thyroid cancer
  4. The Second Antithyroid Drug Treatment Is Effective in Relapsed Graves' Disease Patients: A Median 11-Year Follow-Up Study
  5. Thyroid-Related Protein Expression in the Human Thymus
  6. The Association between Type 2 Diabetes Mellitus and Thyroid Cancer
  7. The effect of TSH-suppression on vertebral trabecular bone scores in patients with differentiated thyroid carcinoma
  8. Long-term Recurrence of Small Papillary Thyroid Cancer and Its Risk Factors in a Korean Multicenter Study
  9. Recurrence and Survival After Gross Total Removal of Resectable Undifferentiated or Poorly Differentiated Thyroid Carcinoma
  10. Acute High-Dose and Chronic Lifetime Exposure to Alcohol Consumption and Differentiated Thyroid Cancer: T-CALOS Korea
  11. Changes of Clinicopathologic Characteristics and Survival Outcomes of Anaplastic and Poorly Differentiated Thyroid Carcinoma
  12. Annual Average Changes in Adult Obesity as a Risk Factor for Papillary Thyroid Cancer
  13. The effect of thyroid stimulating hormone suppressive therapy on bone geometry in the hip area of patients with differentiated thyroid carcinoma
  14. Abstract B61: Effects of metformin on papillary thyroid cancer apoptosis and autophagy
  15. High Serum Levels of Thyroid-Stimulating Hormone and Sustained Weight Gain in Patients with Thyroid Cancer Undergoing Radioiodine Therapy
  16. Dietary evaluation of a low-iodine diet in Korean thyroid cancer patients preparing for radioactive iodine therapy in an iodine-rich region
  17. The Presence of Thyroid-Stimulation Blocking Antibody Prevents High Bone Turnover in Untreated Premenopausal Patients with Graves’ Disease
  18. A Possible Association Between Thyroid Cancer and Breast Cancer
  19. CXCL16 signaling mediated macrophage effects on tumor invasion of papillary thyroid carcinoma
  20. Influence of thyroid dysfunction on serum levels of angiopoietin-like protein 6
  21. Radioactive Iodine Therapy Did Not Significantly Increase the Incidence and Recurrence of Subsequent Breast Cancer
  22. Abstract 2134: Standard immunohistochemistry efficiently screens for ALK rearrangements in differentiated thyroid cancer
  23. Postoperative biochemical remission of serum calcitonin is the best predictive factor for recurrence-free survival of medullary thyroid cancer: a large-scale retrospective analysis over 30 years
  24. Long-term oral exposure to bisphenol A induces glucose intolerance and insulin resistance
  25. The effect of TSH suppression therapy on the cortical bone geometry in the patients with differentiated thyroid cancer
  26. Pediatric Patients With Multifocal Papillary Thyroid Cancer Have Higher Recurrence Rates Than Adult Patients: A Retrospective Analysis of a Large Pediatric Thyroid Cancer Cohort Over 33 Years
  27. Factors Affecting the Locoregional Recurrence of Conventional Papillary Thyroid Carcinoma After Surgery: A Retrospective Analysis of 3381 Patients
  28. Differences in Physicians' and Patients' Perception of Acute Hypothyroid Symptoms Induced by Thyroid Hormone Withdrawal in Thyroid Cancer Patients: A Multicenter Survey in Korea
  29. Mutation Profile of Well-Differentiated Thyroid Cancer in Asians
  30. Expression of the embryonic morphogen Nodal in differentiated thyroid carcinomas: Immunohistochemistry assay in tissue microarray and The Cancer Genome Atlas data analysis
  31. Serum thyroglobulin level after radioiodine therapy (Day 3) to predict successful ablation of thyroid remnant in postoperative thyroid cancer
  32. Subclinical hypothyroidism in addition to common risk scores for prediction of cardiovascular disease: a 10-year community-based cohort study
  33. Secular trends in the prognostic factors for papillary thyroid cancer
  34. Abstract 2163: Height, weight and weight changes during adulthood and thyroid cancer risk
  35. Expression of Indoleamine 2,3-Dioxygenase and Infiltration of FOXP3+ Regulatory T Cells Are Associated with Aggressive Features of Papillary Thyroid Microcarcinoma
  36. Low Iodine Diet for One Week Is Sufficient for Adequate Preparation of High Dose Radioactive Iodine Ablation Therapy of Differentiated Thyroid Cancer Patients in Iodine-Rich Areas
  37. Loss of ERβ expression in papillary thyroid carcinoma is associated with recurrence in young female
  38. Diabetes Mellitus and Risk of Thyroid Cancer: A Meta-Analysis
  39. Long-Term Prognosis of Differentiated Thyroid Cancer with Lung Metastasis in Korea and Its Prognostic Factors
  40. Prevalence and Risk Factors of Subclinical Thyroid Disease
  41. Case of Synchronous Central Neck Node Metastases from Both Primary Thyroid Cancer and from Endometrial Cancer to the Thyroid
  42. Effect of Seasonal Changes on the Transition Between Subclinical Hypothyroid and Euthyroid Status
  43. Changes in the Clinicopathological Characteristics and Outcomes of Thyroid Cancer in Korea over the Past Four Decades
  44. Associations between thyroid hormone levels and regional fat accumulation in euthyroid men
  45. Expression of Thyroid Stimulating Hormone Receptor mRNA in Mouse C2C12 Skeletal Muscle Cells
  46. A case of mediastinal ectopic thyroid presenting with a paratracheal mass
  47. Korean Thyroid Association Guidelines for Patients Undergoing Radioiodine Therapy for Differentiated Thyroid Cancers (First Edition, 2012)
  48. The Expression of Tumor-Associated Macrophages in Papillary Thyroid Carcinoma
  49. Association between low serum free thyroxine concentrations and coronary artery calcification in healthy euthyroid subjects
  50. The Long-Term Outcomes of the Second Generation of Familial Nonmedullary Thyroid Carcinoma Are More Aggressive than Sporadic Cases
  51. Monogenic Thyroid Disorder
  52. Two Cases of Non-Small Cell Lung Cancer Masquerading as Metastatic Papillary Thyroid Cancer
  53. The association of the BRAFV600E mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer
  54. The Risk of Breast Cancer Is Reduced in Thyroid Cancer Patients after Radioactive Iodine Therapy
  55. Role of core needle biopsy and ultrasonographic finding in management of indeterminate thyroid nodules
  56. Revised Korean Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Thyroid Cancer
  57. Revised Korean Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Thyroid Cancer
  58. Effect of Thyroid Hormone to the Expression of Bile Salt Export Pump
  59. Elevated risk of papillary thyroid cancer in Korean patients with Hashimoto's thyroiditis
  60. Tumor Size and Age Predict the Risk of Malignancy in Hürthle Cell Neoplasm of the Thyroid and Can Therefore Guide the Extent of Initial Thyroid Surgery
  61. Revised Korean Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Thyroid Cancer
  62. Endothelial Function is Not Changed during Short-Term Withdrawal of Thyroxine in Patients with Differentiated Thyroid Cancer and Low Cardiovascular Risk
  63. Papillary microcarcimoma in comparison with larger papillary thyroid carcinoma in BRAF V600E mutation, clinicopathological features, and immunohistochemical findings
  64. S100A4 expression is associated with lymph node metastasis in papillary microcarcinoma of the thyroid
  65. Ghrelin enhances the proliferating effect of thyroid stimulating hormone in FRTL-5 thyroid cells
  66. Susceptible Alleles of the CD40 and CTLA-4 Genes Are Not Associated with the Relapse after Antithyroid Withdrawal in Graves' Disease
  67. Mediastinal Uptake Misinterpreted as Metastasis in Papillary Thyroid Cancer
  68. Microarray Analysis of Thyroid Stimulating Hormone, Insulin-Like Growth Factor-1, and Insulin-Induced Gene Expression in FRTL-5 Thyroid Cells
  69. Clinical Features and Prognostic Factors for Survival in Patients with Poorly Differentiated Thyroid Carcinoma and Comparison to the Patients with the Aggressive Variants of Papillary Thyroid Carcinoma
  70. 155-P
  71. Analysis of differential BRAFV600E mutational status in multifocal papillary thyroid carcinoma
  72. A C/T Polymorphism in the 5′-Untranslated Region of the CD40 Gene is Associated with Graves' Disease in Koreans
  73. The Prevalence and Clinical Significance of Blocking Thyrotropin Receptor Antibodies in Untreated Hyperthyroid Graves' Disease